Posted inComunicati
NewAmsterdam Pharma and Menarini Group Receive Positive CHMP Opinion Recommending Marketing Authorization for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)
COMUNICATO STAMPA - CONTENUTO PROMOZIONALE - Positive CHMP opinion supports potential commercialization of obicetrapib monotherapy…









